HOW DIET THERAPY AFFECTS OBESITY-ASSOCIATED DEPRESSIVE SYMPTOMS: FROM MECHANISM TO THERAPEUTICS

Descargar Publicación
Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity Tirzepatide and the gut microbiota–obesity axis: metabolic mechanisms and therapeutic perspectives